Understanding Trump's Executive Order on Prescription Drug Pricing: Your Questions Answered

In a recent press briefing, President Donald Trump announced an executive order designed to slash drug prices in the U.S., claiming some reductions could reach up to 90% “almost immediately.” However, the order lacks specific implementation details. The proposed “most favored nation” pricing strategy mandates that U.S. pharmaceutical companies align their prices with the lowest rates in other developed nations. Experts warn the loosely outlined plan may face legal hurdles, as historical precedents suggest that drug manufacturers could manipulate pricing data or withdraw drugs from certain markets. Notably, U.S. prescription drug prices remain significantly higher than abroad. Experts stress that practical challenges abound, including potential resistance from pharmaceutical companies. The order leaves uncertainties about enforcement and its ultimate impact on consumer costs.